JPMORGAN CHASE & CO - PROTHENA CORP PLC ownership

PROTHENA CORP PLC's ticker is PRTA and the CUSIP is G72800108. A total of 187 filers reported holding PROTHENA CORP PLC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTHENA CORP PLC
ValueSharesWeighting
Q3 2023$19,397,997
-31.4%
402,031
-2.9%
0.00%
-33.3%
Q2 2023$28,272,358
+78.0%
414,065
+26.3%
0.00%
+50.0%
Q1 2023$15,885,000
+65071.9%
327,718
-19.0%
0.00%
-33.3%
Q4 2022$24,374
-99.9%
404,551
+43.4%
0.00%
+50.0%
Q3 2022$17,109,000
+119.9%
282,182
-1.5%
0.00%
+100.0%
Q2 2022$7,780,000
-15.6%
286,579
+13.7%
0.00%0.0%
Q1 2022$9,221,000
-13.3%
252,140
+17.1%
0.00%0.0%
Q4 2021$10,638,000
+946.0%
215,342
+1407.4%
0.00%
Q3 2021$1,017,000
+29.2%
14,286
-6.8%
0.00%
Q2 2021$787,000
+168.6%
15,328
+31.5%
0.00%
Q1 2021$293,000
-28.4%
11,659
-65.7%
0.00%
Q4 2020$409,000
+178.2%
33,991
+129.8%
0.00%
Q3 2020$147,000
+2.1%
14,789
+7.7%
0.00%
Q2 2020$144,000
-18.6%
13,738
-16.8%
0.00%
Q1 2020$177,000
-84.9%
16,512
-77.7%
0.00%
Q4 2019$1,174,000
+47.9%
74,127
-26.8%
0.00%
Q3 2019$794,000
-58.5%
101,283
-46.6%
0.00%
Q2 2019$1,913,000
-7.5%
189,645
+11.2%
0.00%
Q1 2019$2,069,000
+302.5%
170,561
+242.1%
0.00%
Q4 2018$514,000
-61.3%
49,861
-50.9%
0.00%
Q3 2018$1,329,000
+1016.8%
101,599
+1145.1%
0.00%
Q2 2018$119,000
-96.6%
8,160
-91.4%
0.00%
-100.0%
Q1 2018$3,498,000
-10.5%
95,292
-8.6%
0.00%0.0%
Q4 2017$3,910,000
-41.8%
104,285
+5.1%
0.00%0.0%
Q3 2017$6,721,000
+23.0%
99,200
-1.8%
0.00%0.0%
Q2 2017$5,465,000
+8.7%
100,975
+12.0%
0.00%0.0%
Q1 2017$5,029,000
+11.7%
90,153
-1.6%
0.00%0.0%
Q4 2016$4,504,000
-19.9%
91,580
-2.3%
0.00%0.0%
Q3 2016$5,624,000
+83.6%
93,780
+7.0%
0.00%0.0%
Q2 2016$3,064,000
-17.8%
87,640
-3.2%
0.00%0.0%
Q1 2016$3,727,000
-36.5%
90,556
+5.0%
0.00%0.0%
Q4 2015$5,873,000
+34.6%
86,223
-10.4%
0.00%0.0%
Q3 2015$4,362,000
-3.9%
96,198
+11.6%
0.00%0.0%
Q2 2015$4,541,000
+26.5%
86,226
-8.4%
0.00%0.0%
Q1 2015$3,590,000
+96.9%
94,125
+7.2%
0.00%
Q4 2014$1,823,000
+601.2%
87,825
+794.3%
0.00%
Q4 2013$260,000
-16.1%
9,820
-35.8%
0.00%
Q3 2013$310,00015,2920.00%
Other shareholders
PROTHENA CORP PLC shareholders Q3 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 11,584,280$558,941,51018.85%
Finepoint Capital LP 349,300$16,853,7258.39%
Palo Alto Investors LP 1,657,458$79,972,3497.57%
Birchview Capital, LP 169,574$8,181,9466.96%
First Light Asset Management, LLC 1,494,039$72,087,3826.85%
DCF Advisers, LLC 82,950$4,002,3382.18%
Prosight Management, LP 126,202$6,089,2471.93%
PFM Health Sciences, LP 836,571$40,364,5511.90%
SECTORAL ASSET MANAGEMENT INC 172,407$8,318,6381.62%
Boxer Capital, LLC 625,000$30,156,2501.60%
View complete list of PROTHENA CORP PLC shareholders